It has been suggested that patients with autosomal recessive merosin d
eficient congenital muscular dystrophy (CMD), as opposed to the merosi
n positive cases form a homogeneous subgroup of a clinically mole seve
re form of CMD. We examined merosin expression in muscle biopsies from
five children with the severe classical form of CMD. Merosin deficien
cy was found only in 1 patient, a 6-year-old female, with abnormal bra
in myelination. However, her initial biopsy did not reveal the classic
al picture of dystrophy. The four merosin positive cases exhibited sev
ere muscle weakness but their brain imagings were normal. There were n
o familial cases, except for the mother of 1 patient who had a milder
form of the disease, suggesting an autosomal dominant mode of inherita
nce. In contrast to previous reports, the merosin deficient CMD cases
were rare in our group. Furthermore, merosin positive cases were also
associated with severe phenotype suggesting that a severe phenotype is
not exclusive to merosin deficient cases. Finally, the absence of mer
osin in a neonate with hypotonia and weakness can be helpful in making
a definitive diagnosis of CMD, even though the dystrophic process may
not be evident yet and histology may be non-specific.